Insulin secretion stimulation via physiological nutrient intake

The term "insulin secretion stimulation via physiological nutrient intake" refers broadly to the process by which pancreatic beta cells sense increases in circulating nutrients—primarily glucose but also amino acids and fatty acids—and respond by releasing stored and newly synthesized insulin into the bloodstream, thereby maintaining blood glucose homeostasis after meals. This involves complex intracellular signaling pathways triggered by metabolism-derived changes in ATP/ADP ratio leading to closure of KATP channels, membrane depolarization, calcium influx through voltage-gated channels, and exocytosis of preformed granules containing mature insulin[5][7]. Additional regulatory layers include amplification signals from gut-derived hormones ("incretins" such as GLP‑1), neural inputs from the enteric nervous system ("gut-brain axis"), autocrine/paracrine factors within pancreatic islets, and modulation through cellular energy sensors like mTORC1 responding specifically to certain amino acids like leucine[2][3]. Disruption or failure in these adaptive responses underlies pathologies such as type 2 diabetes mellitus when increased demand cannot be met due to impaired beta-cell function or mass[1]. This entry should be replaced with more precise targets involved in these pathways—for example: ATP-sensitive potassium channel subunit Kir6.2/SUR1; Glucagon-like peptide 1 receptor (GLP‑1R); Mammalian target of rapamycin complex 1 (mTORC1) depending on context-specific interest within therapeutic development or research applications.

Other names

Nutrient-stimulated insulin secretionGlucose-stimulated insulin secretion (GSIS)Amino acid–stimulated insulin secretionFatty acid–stimulated insulin secretion

Mechanism of action is not applicable for the process itself. However, drugs modulating this pathway operate via: KATP channel inhibition leading to membrane depolarization, calcium influx, and exocytosis of insulin granules; or enhancement of glucose-dependent insulin release through incretin effects via GLP-1 and GIP receptors; or amplification of nutrient-induced signaling in beta cells through mTORC1 modulation by amino acids.